K2M Group Holdings Inc. (NASDAQ:KTWO)’s share price fell 1.5% during trading on Tuesday . The company traded as low as $16.42 and last traded at $16.52, with a volume of 162,913 shares traded. The stock had previously closed at $16.77.

Several equities research analysts recently issued reports on KTWO shares. Piper Jaffray Cos. reissued a “buy” rating and set a $22.00 price objective (down previously from $29.00) on shares of K2M Group Holdings in a research note on Tuesday, May 3rd. Needham & Company LLC reissued a “buy” rating and set a $21.00 price objective on shares of K2M Group Holdings in a research note on Tuesday, May 3rd. Northland Securities lowered K2M Group Holdings from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 3rd. Zacks Investment Research lowered K2M Group Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. Finally, Barclays PLC lifted their price objective on K2M Group Holdings from $20.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, August 4th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $22.20.

The stock’s market cap is $691.18 million. The firm’s 50 day moving average price is $16.84 and its 200-day moving average price is $14.51.

K2M Group Holdings (NASDAQ:KTWO) last announced its earnings results on Wednesday, August 3rd. The medical device company reported ($0.27) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.01. During the same quarter in the prior year, the firm posted ($0.16) earnings per share. The company had revenue of $59.20 million for the quarter, compared to analysts’ expectations of $57.47 million. K2M Group Holdings’s quarterly revenue was up 5.0% on a year-over-year basis. Analysts forecast that K2M Group Holdings Inc. will post ($1.10) EPS for the current fiscal year.

A hedge fund recently raised its stake in K2M Group Holdings stock. Schwab Charles Investment Management Inc. increased its stake in K2M Group Holdings Inc. (NASDAQ:KTWO) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,402 shares of the medical device company’s stock after buying an additional 2,980 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.18% of K2M Group Holdings worth $1,430,000 at the end of the most recent quarter.

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company’s spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.